Cargando…
Changing the Paradigm for the Treatment and Development of New Therapies for FSGS
Focal segmental glomerulosclerosis (FSGS) is a renal pathology finding that represents a constellation of rare kidney diseases, which manifest as proteinuria, edema nephrotic syndrome, hypertension, and increased risk for kidney failure. Therapeutic options for FSGS are reviewed displaying the expec...
Autores principales: | Spino, Cathie, Jahnke, Jordan S., Selewski, David T., Massengill, Susan, Troost, Jonathan, Gipson, Debbie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803734/ https://www.ncbi.nlm.nih.gov/pubmed/27047908 http://dx.doi.org/10.3389/fped.2016.00025 |
Ejemplares similares
-
Therapeutic approach to FSGS in children
por: Gipson, Debbie S., et al.
Publicado: (2007) -
Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge
por: Tran, Cheryl L., et al.
Publicado: (2021) -
Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
por: Weaver, Donald J., et al.
Publicado: (2020) -
Case report: Early onset de novo FSGS in a child after kidney transplantation—a successful treatment
por: Carvajal Abreu, Karla, et al.
Publicado: (2023) -
NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome
por: Gipson, Debbie S., et al.
Publicado: (2017)